References
- Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391:1301–1314. doi:10.1016/S0140-6736(18)30010-229307467
- El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142(6):1264–1273.e1. doi:10.1053/j.gastro.2011.12.06122537432
- Morgan TR, Mandayam S, Jamal MM. Alcohol and hepatocellular carcinoma. Gastroenterology. 2004;127(5 Suppl 1):S87–S96.15508108
- Kanwal F, Kramer JR, Duan Z, Yu X, White D, El-Serag HB. Trends in the burden of nonalcoholic fatty liver disease in a United States cohort of veterans. Clin Gastroenterol Hepatol. 2016;14(2):301–308 e301–302. doi:10.1016/j.cgh.2015.08.010
- Maluccio M, Covey A. Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma. CA Cancer J Clin. 2012;62(6):394–399. doi:10.3322/caac.2116123070690
- Gluer AM, Cocco N, Laurence JM, et al. Systematic review of actual 10-year survival following resection for hepatocellular carcinoma. HPB. 2012;14(5):285–290. doi:10.1111/j.1477-2574.2012.00446.x22487065
- Jiang XM, Yu XN, Huang RZ, et al. Prognostic significance of eukaryotic initiation factor 4E in hepatocellular carcinoma. J Cancer Res Clin Oncol. 2016;142(11):2309–2317. doi:10.1007/s00432-016-2232-227601163
- Islam MR, Kim NS, Jung JW, Kim HB, Han SC, Yang MS. Spontaneous pepsin C-catalyzed activation of human pepsinogen C in transgenic rice cell suspension culture: production and characterization of human pepsin C. Enzyme Microb Technol. 2018;108:66–73. doi:10.1016/j.enzmictec.2017.09.00629108629
- Szecsi PB, Halgreen H, Poulsen SS, et al. Demonstration of pepsinogen C in human pancreatic islets. Gut. 1987;28(10):1208–1214.3315877
- Diaz M, Rodriguez JC, Sanchez J, et al. Clinical significance of pepsinogen C tumor expression in patients with stage D2 prostate carcinoma. Int J Biol Markers. 2002;17(2):125–129.12113579
- Foster C, Aktar A, Kopf D, Zhang P, Guttentag S. Pepsinogen C: a type 2 cell-specific protease. Am J Physiol Lung Cell Mol Physiol. 2004;286(2):L382–L387. doi:10.1152/ajplung.00310.200314578117
- Kageyama T. Pepsinogens, progastricsins, and prochymosins: structure, function, evolution, and development. Cell Mol Life Sci. 2002;59(2):288–306.11915945
- Antunes AA, Leite KR, Sousa-Canavez JM, Camara-Lopes LH, Srougi M. The role of prostate specific membrane antigen and pepsinogen C tissue expression as an adjunctive method to prostate cancer diagnosis. J Urol. 2009;181(2):594–600. doi:10.1016/j.juro.2008.10.00719084862
- Vizoso F, Sanchez LM, Diez-Itza I, Merino AM, Lopez-Otin C. Pepsinogen C is a new prognostic marker in primary breast cancer. J Clin Oncol. 1995;13(1):54–61. doi:10.1200/JCO.1995.13.1.547799043
- Kon OL, Yip TT, Ho MF, et al. The distinctive gastric fluid proteome in gastric cancer reveals a multi-biomarker diagnostic profile. BMC Med Genomics. 2008;1:54. doi:10.1186/1755-8794-1-5418950519
- Miyasaka Y, Enomoto N, Nagayama K, et al. Analysis of differentially expressed genes in human hepatocellular carcinoma using suppression subtractive hybridization. Br J Cancer. 2001;85(2):228–234. doi:10.1054/bjoc.2001.190111461082
- Zhang C, Liu LX, Dong ZR, et al. Up-regulation of 14-3-3zeta expression in intrahepatic cholangiocarcinoma and its clinical implications. Tumor Biol. 2015;36(3):1781–1789. doi:10.1007/s13277-014-2780-5
- Balbin M, Lopez-Otin C. Hormonal regulation of the human pepsinogen C gene in breast cancer cells. Identification of a cis-acting element mediating its induction by androgens, glucocorticoids, and progesterone. J Biol Chem. 1996;271(25):15175–15181.8663058
- Konishi N, Nakaoka S, Matsumoto K, et al. Expression of pepsinogen II with androgen and estrogen receptors in human prostate carcinoma. Pathol Int. 1999;49(3):203–207.10338074
- Gonzalez LO, Corte MD, Junquera S, Bongera M, Rodriguez JC, Vizoso FJ. Expression of androgen receptor and two androgen-induced proteins (apolipoprotein D and pepsinogen C) in ductal carcinoma in situ of the breast. Histopathology. 2007;50(7):866–874. doi:10.1111/j.1365-2559.2007.02687.x17543076
- Antunes AA, Reis ST, Leite KR, et al. PGC and PSMA in prostate cancer diagnosis: tissue analysis from biopsy samples. Int Braz J Urol. 2013;39(5):649–656. doi:10.1590/S1677-5538.IBJU.2013.05.0624267108
- Rojo JV, Merino AM, Gonzalez LO, Vizoso F. Expression and clinical significance of pepsinogen C in epithelial ovarian carcinomas. Eur J Obstet Gynecol Reprod Biol. 2002;104(1):58–63.12128264
- Diez-Itza I, Merino AM, Tolivia J, Vizoso F, Sanchez LM, Lopez-Otin C. Expression of pepsinogen C in human breast tumours and correlation with clinicopathologic parameters. Br J Cancer. 1993;68(3):637–640.8353054